KERTUSHA, BLERTA
 Distribuzione geografica
Continente #
EU - Europa 290
NA - Nord America 276
AS - Asia 60
AF - Africa 4
OC - Oceania 1
Totale 631
Nazione #
US - Stati Uniti d'America 269
IT - Italia 212
SG - Singapore 30
SE - Svezia 23
IN - India 18
BG - Bulgaria 14
IE - Irlanda 9
DE - Germania 8
FR - Francia 7
CA - Canada 6
CN - Cina 6
RO - Romania 5
GB - Regno Unito 4
PH - Filippine 3
HK - Hong Kong 2
MK - Macedonia 2
NG - Nigeria 2
NL - Olanda 2
AL - Albania 1
AU - Australia 1
FI - Finlandia 1
HU - Ungheria 1
MX - Messico 1
MY - Malesia 1
TG - Togo 1
TZ - Tanzania 1
UA - Ucraina 1
Totale 631
Città #
Rome 72
Milan 44
Fairfield 40
Chandler 29
Ashburn 28
Houston 17
New York 14
Sofia 14
Woodbridge 14
Cambridge 12
Seattle 12
Wilmington 11
Dearborn 10
Dublin 9
Singapore 9
Princeton 8
Artena 7
San Paolo di Civitate 6
Fremont 5
Boston 4
Induno Olona 4
Lawrence 4
Sabaudia 4
San Diego 4
Andover 3
Ann Arbor 3
Barrie 3
Dasmariñas 3
Pune 3
Toronto 3
Abuja 2
Amsterdam 2
Beijing 2
Des Moines 2
Falls Church 2
Fuzhou 2
Genoa 2
Hong Kong 2
Lingolsheim 2
Naples 2
Negrar 2
Osimo 2
Plano 2
Rho 2
Ribera 2
Acton 1
Anandanagar 1
Baotou 1
Bremen 1
Budapest 1
Bühl 1
Civita Castellana 1
Clifton 1
Colle Di Val D'elsa 1
Grafing 1
Helsinki 1
Kilburn 1
Lomé 1
London 1
Los Angeles 1
Mannheim 1
Mexico City 1
Millbury 1
Mondragone 1
Munich 1
Norwalk 1
Nuremberg 1
Padova 1
Phoenix 1
Prato 1
San Jose 1
San Mateo 1
Saviano 1
Schopfheim 1
Seriate 1
Stockholm 1
Trumbull 1
Venafro 1
Verona 1
Totale 463
Nome #
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection 110
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 100
Epidemiology and microbiology of skin and soft tissue infections: preliminary results of a National registry 70
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 66
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 62
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme. Convergent or divergent action? 61
Use of remdesivir in patients with SARS-CoV-2 Pneumonia in a real-life setting during the second and third COVID-19 epidemic waves 45
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients 43
Quality of t-cell response to SARS-CoV-2 mrrna vaccine in art-treated plwh 27
Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use 27
Longitudinal virological and immunological profile in a case of human monkeypox infection 27
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli 21
Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects 11
null 9
Effectiveness, tolerability and prescribing choice of antiviral molecules molnupiravir, remdesivir and nirmatrelvir/r. A real-world comparison in the first ten months of use 5
null 3
Totale 687
Categoria #
all - tutte 2.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 7 2 0 4 7 13 10 6 9 4 2 1
2020/202172 2 5 0 0 0 4 0 2 29 12 6 12
2021/2022125 4 9 26 7 15 2 9 6 3 2 28 14
2022/2023166 20 22 12 17 16 20 0 12 11 1 20 15
2023/2024228 12 8 7 17 21 49 9 6 3 57 24 15
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 687